Association Between Kidney Disease Index and Decline in Cognitive Function with Mediation by Arterial Stiffness in Asians with Type 2 Diabetes.

Alzheimer’s disease cognitive function kidney disease index type 2 diabetes

Journal

Journal of Alzheimer's disease reports
ISSN: 2542-4823
Titre abrégé: J Alzheimers Dis Rep
Pays: Netherlands
ID NLM: 101705500

Informations de publication

Date de publication:
2024
Historique:
received: 09 04 2024
accepted: 16 07 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

Decline in renal function impairs systemic clearance of amyloid-β which characterizes Alzheimer's disease while albuminuria is associated with blood-brain barrier disruption due to endothelial damage. Arterial stiffness adversely affects the brain with high pulsatile flow damaging cerebral micro-vessels. To examine association between a novel kidney disease index (KDI), which is a composite index of estimated glomerular filtration (eGFR) and urinary albumin-to-creatinine ratio (uACR), and cognitive function with potential mediation by arterial stiffness. This was a longitudinal multi-center study of participants with type 2 diabetes (T2D) aged 45 years and above. We assessed cognitive function with Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Pulse wave velocity (PWV), an index of arterial stiffness, was measured using applanation tonometry method. KDI was calculated as geometric mean of 1/eGFR and natural logarithmically-transformed (ln)(ACR*100). There were 1,303 participants with mean age 61.3±8.0 years. LnKDI was associated with lower baseline RBANS total score with adjusted coefficient -2.83 (95% CI -4.30 to -1.35; KDI was associated with lower cognitive function globally, and in immediate memory, visuo-spatial/construction and attention domains. Arterial stiffness mediated the association between KDI and cognitive decline in patients with T2D.

Sections du résumé

Background UNASSIGNED
Decline in renal function impairs systemic clearance of amyloid-β which characterizes Alzheimer's disease while albuminuria is associated with blood-brain barrier disruption due to endothelial damage. Arterial stiffness adversely affects the brain with high pulsatile flow damaging cerebral micro-vessels.
Objective UNASSIGNED
To examine association between a novel kidney disease index (KDI), which is a composite index of estimated glomerular filtration (eGFR) and urinary albumin-to-creatinine ratio (uACR), and cognitive function with potential mediation by arterial stiffness.
Methods UNASSIGNED
This was a longitudinal multi-center study of participants with type 2 diabetes (T2D) aged 45 years and above. We assessed cognitive function with Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Pulse wave velocity (PWV), an index of arterial stiffness, was measured using applanation tonometry method. KDI was calculated as geometric mean of 1/eGFR and natural logarithmically-transformed (ln)(ACR*100).
Results UNASSIGNED
There were 1,303 participants with mean age 61.3±8.0 years. LnKDI was associated with lower baseline RBANS total score with adjusted coefficient -2.83 (95% CI -4.30 to -1.35;
Conclusions UNASSIGNED
KDI was associated with lower cognitive function globally, and in immediate memory, visuo-spatial/construction and attention domains. Arterial stiffness mediated the association between KDI and cognitive decline in patients with T2D.

Identifiants

pubmed: 39247878
doi: 10.3233/ADR-240067
pii: ADR240067
pmc: PMC11380277
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1199-1210

Informations de copyright

© 2024 – The authors. Published by IOS Press.

Déclaration de conflit d'intérêts

The authors have no conflict of interest to report.

Auteurs

Serena Low (S)

Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.
Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Angela Moh (A)

Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.

Kiat Sern Goh (KS)

Department of Geriatric Medicine, Changi General Hospital, Singapore.

Jonathon Khoo (J)

Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.

Keven Ang (K)

Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.

Allen Yan Lun Liu (AYL)

Department of Renal Medicine, Khoo Teck Puat Hospital, Singapore, Singapore.

Wern Ee Tang (WE)

National Healthcare Group Polyclinics, Singapore, Singapore.

Ziliang Lim (Z)

National Healthcare Group Polyclinics, Singapore, Singapore.

Tavintharan Subramaniam (T)

Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.

Chee Fang Sum (CF)

Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.

Su Chi Lim (SC)

Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.
Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

Classifications MeSH